More about

Myocardial Fibrosis

News
October 28, 2024
3 min read
Save

Aortic valve replacement benefit uncertain in asymptomatic disease with myocardial fibrosis

WASHINGTON — Among patients with asymptomatic severe aortic stenosis and myocardial fibrosis, transcatheter or surgical aortic valve replacement did not improve outcomes compared with guideline-directed conservative management.

News
November 16, 2021
1 min read
Save

Air pollution linked to myocardial fibrosis in patients with CKD

Increased exposure to air pollution may lead to higher risk for myocardial fibrosis in patients with chronic kidney disease, according to a speaker at ASN Kidney Week.

News
August 18, 2021
2 min read
Save

Preterm-born young adults exhibit greater extracellular volume fraction in left ventricle

In a new study, young adults born preterm demonstrated increased extracellular volume fraction in the left ventricle compared with their term-born peers, which may underlie their diastolic functional impairments.

News
June 16, 2021
2 min read
Save

HIV confers elevated rates of sudden cardiac death, myocardial fibrosis

Compared with those without HIV, HIV-positive individuals had higher rates of sudden cardiac death and myocardial fibrosis, and one-third of sudden cardiac deaths in people with HIV were due to occult drug overdose, researchers reported.

News
May 17, 2021
1 min read
Save

PIROUETTE: Pirfenidone reduces myocardial fibrosis in patients with HFpEF

In patients with HF with preserved ejection fraction, pirfenidone was associated with reduction in myocardial fibrosis compared with placebo, according to a presentation at the American College of Cardiology Scientific Session.

News
April 14, 2021
1 min read
Save

Myocardial fibrosis, LV remodeling may predict CV events in people living with HIV

For patients living with HIV on long-term highly active antiretroviral therapy, diffuse myocardial fibrosis and left ventricular remodeling may be predictive of adverse CV events, according to data published in JACC: Cardiovascular Imaging.

News
May 01, 2020
1 min read
Save

Galectin-3 may modify CV mortality risk via aldosterone

Galectin-3 interacted with risk for fatal CV events associated with aldosterone in patients referred for coronary angiography, according to a study published in The American Journal of Cardiology.

News
March 30, 2020
3 min read
Save

Mavacamten shows promise in nonobstructive hypertrophic cardiomyopathy

In patients with nonobstructive hypertrophic cardiomyopathy, treatment with mavacamten was well tolerated and reduced biomarkers of cardiac injury and wall stress, according to results of the phase 2 MAVERICK-HCM study.